PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations
Clinical trial NCT03609619 · COMPLETED
Trial details
- NCT number
- NCT03609619
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-17
- Primary completion
- 2018-11-23
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.